| May 21, 2013 Karolinska Development Presented at Avanza Bank Börsdag, Stockholm Cick Here to View the Webcast (Swedish) >> |
 |
Press Releases
-
2013-06-19
Athera and Boehringer Ingelheim enter into an option agreement on a novel therapy for Atherosclerosis
-
2013-06-17
EU grants EUR 6m to the clinical development of Athera´s cardiovascular disease antibody therapy
-
2013-05-23
First patient dosed in the Phase I/II study of Umecrine Mood’s candidate drug for premenstrual dysphoric disorder
News
- 2012-04-09 Aprea AB
Aprea presents preclinical data at AACR - Strong synergistic effect with APR-246 and cisplatin - 2013-04-03 Aprea AB
Aprea to present at the American Association for Cancer Research (AACR) annual meeting in Washington, DC, in April 2013 - 2013-02-05 BioArctic Neuroscience AB
Alzheimer antibody enters into Phase IIb - 2013-01-21 Axelar AB
Investigator sponsored Phase I/II study of AXL1717 in patients with brain tumors started in the US